164 related articles for article (PubMed ID: 7708087)
1. In vitro and in vivo antifungal activities of liposomal amphotericin B, and amphotericin B lipid complex.
Mitsutake K; Kohno S; Miyazaki Y; Noda T; Miyazaki H; Miyazaki T; Kaku M; Koga H; Hara K
Mycopathologia; 1994 Oct; 128(1):13-7. PubMed ID: 7708087
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B lipid complex therapy of experimental fungal infections in mice.
Clark JM; Whitney RR; Olsen SJ; George RJ; Swerdel MR; Kunselman L; Bonner DP
Antimicrob Agents Chemother; 1991 Apr; 35(4):615-21. PubMed ID: 2069367
[TBL] [Abstract][Full Text] [Related]
3. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
[TBL] [Abstract][Full Text] [Related]
4. In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis.
Warn PA; Morrissey J; Moore CB; Denning DW
Antimicrob Agents Chemother; 2000 Oct; 44(10):2664-71. PubMed ID: 10991841
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
Andes D; Safdar N; Marchillo K; Conklin R
Antimicrob Agents Chemother; 2006 Feb; 50(2):674-84. PubMed ID: 16436726
[TBL] [Abstract][Full Text] [Related]
7. Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis.
Clemons KV; Stevens DA
J Antimicrob Chemother; 1992 Sep; 30(3):353-63. PubMed ID: 1452501
[TBL] [Abstract][Full Text] [Related]
8. Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.
van Etten EW; Chander HR; Snijders SV; Bakker-Woudenberg IA
J Antimicrob Chemother; 1995 Dec; 36(6):961-74. PubMed ID: 8821595
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of liposomal and conventional amphotericin B in a mouse model of systemic infection with Candida albicans.
Kretschmar M; Bertsch T; Nichterlein T
J Chemother; 2004 Jun; 16(3):255-8. PubMed ID: 15330321
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important?
Swenson CE; Perkins WR; Roberts P; Ahmad I; Stevens R; Stevens DA; Janoff AS
Antimicrob Agents Chemother; 1998 Apr; 42(4):767-71. PubMed ID: 9559780
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of amphotericin B lipid complex in laboratory animals.
Olsen SJ; Swerdel MR; Blue B; Clark JM; Bonner DP
J Pharm Pharmacol; 1991 Dec; 43(12):831-5. PubMed ID: 1687580
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice.
Karyotakis NC; Anaissie EJ
Antimicrob Agents Chemother; 1994 Nov; 38(11):2660-2. PubMed ID: 7872764
[TBL] [Abstract][Full Text] [Related]
13. Treatment of a murine model of systemic candidiasis with liposomal amphotericin B bearing antibody to Candida albicans.
Hospenthal D; Gretzinger K; Rogers A
J Med Microbiol; 1989 Nov; 30(3):193-7. PubMed ID: 2685314
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
15. Liposome-encapsulated amphotericin B in the treatment of experimental murine candidiasis.
Miyazaki T; Kohno S; Kaku M; Koga H; Yamaguchi K
Tohoku J Exp Med; 1990 Aug; 161(4):273-81. PubMed ID: 2256101
[TBL] [Abstract][Full Text] [Related]
16. Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P.
Carrillo-Muñoz AJ; Ruesga M; Brio S; del Valle O; Rodriguez V; Santos P; Hernández-Molina JM; Cantón E; Pemán J; Guarro J; Quindós G
Chemotherapy; 2002 Dec; 48(5):224-31. PubMed ID: 12476038
[TBL] [Abstract][Full Text] [Related]
17. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
18. Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice.
van Etten EW; van den Heuvel-de Groot C; Bakker-Woudenberg IA
J Antimicrob Chemother; 1993 Nov; 32(5):723-39. PubMed ID: 8125837
[TBL] [Abstract][Full Text] [Related]
19. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
Karlowsky JA; Hoban DJ; Zhanel GG; Goldstein BP
Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.
Wingard JR; White MH; Anaissie E; Raffalli J; Goodman J; Arrieta A;
Clin Infect Dis; 2000 Nov; 31(5):1155-63. PubMed ID: 11073745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
